Home › Funds › Ally Bridge Group (NY) LLC › EWTX

Ally Bridge Group (NY) LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Ally Bridge Group (NY) LLC reported holding 83,300 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.4M, representing 2.99% of its reported portfolio and ranking #9 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed EWTX holdings in 6 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)83.30K sh
Reported value held$3.38M
Portfolio Weight2.99%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's EWTX position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in EWTX in Q3 2024 at 187,695 shares (US$5.0M). The position peaked in Q1 2026 at 161,000 shares, worth US$5.1M. Across 6 filings, Ally Bridge Group (NY) LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 83,300 shares valued at US$3.4M — a reduction of -77,700 shares quarter over quarter.. Notable position changes include a 56% trim in Q4 2024 (shares fell 18% over the following quarter), a 48% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 187.69K $5.01M New
Q4 2024 83.18K $2.22M Reduce
Q1 2025 100.00K $2.20M Add
Q4 2025 195.00K $4.84M New
Q1 2026 161.00K $5.07M Reduce
Q2 2026 83.30K $3.38M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held EWTX?

Ally Bridge Group (NY) LLC has disclosed EWTX holdings in 6 of the last 8 reported quarters, going back to Q3 2024.

What is Ally Bridge Group (NY) LLC's current position in EWTX?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 83.30K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $3.38M, representing 2.99% of its reported portfolio and ranking #9.

Has Ally Bridge Group (NY) LLC been buying or selling EWTX?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC reduced its position in EWTX. The position peaked in Q1 2026 at 161.00K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.